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disease and medical expenses of the metabolic syndrome are
higher than that of non metabolic syndrome.
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OBJECTIVES: This paper describes the trends of costs per case
for both inpatients and outpatients in Alberta, Canada from
February 2001 to May 2004. METHODS: Data on length of
stay, direct costs, indirect costs, average costs per case and
number of cases studied by the 478 Case Mix Groups with
4 complexity levels (for inpatients) and 430 groups of the
Ambulatory Care Classiﬁcation Systems (for outpatients) were
retrieved from the annual reports of health costing in Alberta.
RESULTS: During the studied period, direct costs of medical
services considerably increased while overhead costs for admin-
istrative services, human resources, IT, maintenance, registration,
records and food services slightly increased thereby lowering the
share of indirect costs from 26% in February 2001 to 21% in
May 2004 for both inpatients and outpatients. On average, the
average costs per case yearly increased by 10.5% for outpatients
and 8.2%, 10.5%, 8.9% and 10.9% for inpatients with com-
plexity levels of 1, 2, 3, and 4, respectively. The results also
showed that average length of stay per inpatient case over this
period of time increased in all complexity levels, indicating that
not only price of health services but also the quantity of health
services increased. Driven factors of the increase in price of
health services could be medical price inﬂation, growth in inten-
sity of health services, and growth in defensive medicine which
could also contribute to the increase in quantity of health ser-
vices. However, these need further investigations. CONCLU-
SION: In conclusion, the increasing trend of patient costs per
case from February 2001 to May 2004 is one of the evidences
explaining the skyrocketing growth of overall health care costs in
the province of Alberta, Canada during the same time period.
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OBJECTIVES: The purpose of this analysis was to review medi-
cation adherence issues among patients with chronic disease and
among solid-organ-transplant recipients to elucidate the clinical
and economic impact of nonadherence and to explore the poten-
tial impact of reducing drug-regimen complexity on adherence
and outcomes. METHODS: We conducted a targeted literature
review to outline adherence rates and to summarize the clinical
and economic outcomes of nonadherence, for both chronic-
disease patients and patients receiving post-transplant immuno-
suppression. The impact of dosing complexity on adherence rates
was also reviewed. RESULTS: Typical adherence rates among
chronic-disease patients are approximately 50%, and these low
adherence rates have an estimated economic impact of $100–300
billion annually in the US. Among adult renal transplant recipi-
ents in the US, the median rate of nonadherence is 22%; it is
associated with an estimated 903 acute rejection episodes, 1319
graft losses (36% of transplant failures), and costs approaching
$115 million annually. An inverse relationship exists between
dosing frequency and adherence in various chronic diseases, with
once-daily dosing resulting in the highest adherence rates. Reduc-
ing drug regimen complexity may positively impact clinical and
patient-reported outcomes, as well as health care costs. Overall
costs are reduced when the costs of less frequently administered
drugs are outweighed by the savings achieved through improved
adherence rates and better health outcomes. CONCLUSION: If
trends among patients with chronic diseases apply, once-daily
dosing regimens may improve adherence rates by approximately
6–14% among renal transplant patients and could substantially
reduce the number and costs of acute rejection episodes and graft
failures. Further research is needed to determine the exact clinical
and economic impact of these regimens.
PHP26
THE EFFECT OF INJURY SEVERITY ANDTRAUMA CENTER
DESIGNATION ON INPATIENT COSTS AND OUTCOMES IN
HOSPITAL ADMISSIONS FORTRAUMATIC INJURY INTHE
UNITED STATES
Davis KL1, Candrilli SD1, Mitra D1,Tortella BJ2, Joshi AV2
1RTI Health Solutions, Research Triangle Park, NC, USA,
2Novo Nordisk Inc, Princeton, NJ, USA
OBJECTIVES: To generate national estimates of the effect of
injury severity and admitting facilities’ trauma center designation
on inpatient costs, length of stay (LOS), and probability of
death in hospital admissions for traumatic injury in the US.
METHODS: Discharge data from the 2002 HCUP Nationwide
Inpatient Sample were analyzed for 54,370 admissions (weighted
N = 267,306) to US trauma centers for blunt or penetrating
traumatic injury. Data on admitting facilities’ trauma center des-
ignation (Level I, II, or III/IV) were obtained from the American
Hospital Association. For each admission, injury severity was
calculated using the ICDMAP90 software. Regression analyses
were used to estimate the incremental effect of injury severity
and admitting facilities’ trauma level on inpatient costs, LOS,
and probability of death, controlling for injury type and
other patient characteristics. RESULTS: Relative to critical inju-
ries (ISS = 25+), low severity (ISS = 0–9), moderate severity
(ISS = 10–15) and severe (ISS = 16–24) injuries were associated
with substantially decreased costs (-$7467, -$6592, and
-$5537, respectively; all P < 0.0001), LOS (-9.7, -8.3, and -5.3
days, respectively; all P < 0.0001), and probability of death (odds
ratios = 0.032, 0.046, and 0.077, respectively; all P < 0.0001).
Relative to Level I trauma centers, Level II and Level III/IV
centers were associated with lower costs (-$3407 [P = 0.0051]
and -$4454 [P < 0.0001], respectively), LOS (-0.6 [P = 0.0505]
and -1.8 [P < 0.0001] days, respectively), and probability of
death (odds ratios = 0.818 [P = 0.0090] and 0.732 [P = 0.0515],
respectively). CONCLUSION: To our knowledge, this is the ﬁrst
study to quantify the incremental effect of injury severity and
admitting facilities’ trauma center designation on inpatient costs,
LOS, and probability of death in a representative multi-payer US
population. Higher injury severity, as well as admission to more
specialized trauma centers, was associated with increased costs,
LOS, and probability of death. Results of this study may help
health care decision makers more efﬁciently allocate resources for
treatment of traumatic injuries.
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OBJECTIVES: We previously reported a regression approach
designed to improve the predictive accuracy of risk adjustment
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